IP Library Granted Patent US 10,059,939
Granted Patent B2
US 10,059,939 · App. 13/323,567 · Granted Aug 28, 2018

Screening methods for human embryonic stem cells

Inventors: Ramkumar Mandalam (Union City, CA); Chunhui Xu (Cupertino, CA); Joseph D. Gold (San Francisco, CA); Melissa K. Carpenter (Castro Valley, CA)
Assignee: Asterias Biotherapeutics, Inc.
C12N15/1096C12N5/0606C12N5/0619C12N5/0622C12N15/1034C12N5/0062C12N5/0068C12N5/0075C12N5/0603C12N5/0607C12N5/068C12N5/0662C12N5/0671C12N5/0672C12N5/0678C12N5/0692C12N5/0693C12N5/0696C12N11/04C12N2500/25C12N2500/90C12N2500/98C12N2500/99C12N2501/065C12N2501/105C12N2501/115C12N2501/119C12N2501/125C12N2501/13C12N2501/145C12N2501/155C12N2501/235C12N2501/2306C12N2501/237C12N2501/26C12N2501/998C12N2502/13C12N2502/99C12N2503/02C12N2506/02C12N2510/00C12N2510/04C12N2533/50C12N2533/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,059,939
App. No.
13/323,567
Granted
Aug 28, 2018
Kind
B2
Abstract

This disclosure provides an improved system for culturing human pluripotent stem cells. Traditionally, pluripotent stem cells are cultured on a layer of feeder cells (such as mouse embryonic fibroblasts) to prevent them from differentiating. In the system described here, the role of feeder cells is replaced by components added to the culture environment that support rapid proliferation without differentiation. Effective features are a suitable support structure for the cells, and an effective medium that can be added fresh to the culture without being preconditioned by another cell type. Culturing human embryonic stem cells in fresh medium according to this invention causes the cells to expand surprisingly rapidly, while retaining the ability to differentiate into cells representing all three embryonic germ layers. This new culture system allows for bulk proliferation of pPS cells for commercial production of important products for use in drug screening and human therapy.

Claims (11)

1. A method of screening a factor for its effect on a primate pluripotent stem (pPS) cell, comprising:

a) obtaining an undifferentiated pPS cell cultured essentially feeder free on an extracellular matrix in a non-conditioned nutrient media comprising fibroblast growth factor (FGF);

b) contacting the pPS cell with the factor; and

c) detecting any change in the pPS cell.

2. The method of claim 1 , further comprising allowing the pPS cell to differentiate before step b).

3. The method of claim 1 , wherein the factor is a small molecule drug.

4. The method of claim 1 , wherein the factor is a peptide.

5. The method of claim 1 , wherein the factor is a differentiation factor.

6. The method of claim 1 , wherein the detected change is cytotoxicity.

7. The method of claim 1 , wherein the detected change is a change in cellular morphology.

8. The method of claim 1 , wherein the detected change is a change in marker expression.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2013
From: GERON CORPORATION
To: ASTERIAS BIOTHERAPEUITCS, INC.
Reel/Frame 031578/0054 →
Continuity (15)
Continuation 12763884 · Apr 20, 2010
Continuation 12710078 · Feb 22, 2010
Continuation 12170219 · Jul 9, 2008
Continuation 10235094 · Sep 4, 2002
Continuation In Part 10948956 · Sep 24, 2004
Continuation In Part 09849022 · May 4, 2001
Continuation In Part 10235094 · Sep 4, 2002
Continuation In Part 09530346
Provisional Application 60317478 · Sep 5, 2001
Provisional Application 60175581 · Jan 11, 2000
Provisional Application 60213740 · Jun 22, 2000
Provisional Application 60213739 · Jun 22, 2000
Provisional Application 60216387 · Jul 7, 2000
Provisional Application 60220064 · Jul 21, 2000
Related Publication 20120149025A1 · Jun 14, 2012